Tel: Fax:
|
|
- Leona Harrington
- 5 years ago
- Views:
Transcription
1 CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M. Deshpande and R. N. Jones,, The JONES Group/JMI Laboratories, North Liberty IA and Tufts University School of Medicine, Boston, MA, USA Tel: Fax: BAL has been reported to have inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA), many enterococci, and streptococci with various resistant patterns. BAL potency was assessed by time±kill curves alone or with subinhibitory concentrations of gentamicin (MIC/). BAL exhibited bactericidal activity alone against all the streptococci and staphylococci. Among ampicillin-susceptible enterococci, BAL was bactericidal against some strains, but no BAL inhibition was observed of ampicillin-resistant Enterococcus faecium. The activity of BAL with gentamicin was slightly enhanced (not synergy) or indifferent against staphylococci. BAL demonstrated bactericidal action alone against Enterococcus faecalis and some E. faecium strains (. to. log CFU/mL), but static effects were also noted. Drug interactions with gentamicin showed early synergy (± h) for all enterococci, and indifference or synergy at h (no antagonism). BAL ( mg/l) showed promising bactericidal activity alone and synergy with gentamicin against some of the vancomycin-resistant enterococci tested. Keywords BAL, MRSA, bactericidal Accepted October Clin Microbiol Infect ; : ± BAL is an antistaphylococcal cephalosporin with additional antimicrobial qualities similar to those of a `fourth-generation' cephalosporin. BAL showed excellent in vitro activity against multiresistant Staphylococcus spp. (including methicillin-resistant strains), streptococci, and a wide range of Gram-negative pathogenic bacteria [±]. The anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of BAL originates from its high af nity for and ef cient inhibition of PBP. The PBP functions as a transpeptidase, and is not ef ciently inhibited by many clinically available b-lactams, such as carbapenems, cephalosporins and penicillins. Since BAL shows all the properties of an advanced-spectrum cephalosporin, in addition to the greater Gram-positive activity, we investigated the bactericidal action and the possibility of synergistic interactions of the b-lactam± aminoglycoside combination. BAL activity was tested against streptococci, staphylococci and enterococci. The strains were recent clinical isolates from bacteremic patients, standard quality control strains [,] or well characterized resistant organisms. The clinical isolates were from different nations and continents (USA, Canada, Europe, and Latin America), forming a diverse geographic sample. Representatives of various resistant phenotypes pertinent to each genus or species group were included (Tables and ). These isolates were, however, susceptible to BAL by interpretive criteria established for this study []. The manufacturer (Basilea Pharmaceuticals, Basel, Switzerland) supplied the BAL powder; and the gentamicin was purchased from Sigma Chemicals (St Louis, MO, USA). Bactericidal activity as well as synergy was determined by time±kill curve methodology, ß Copyright by the European Society of Clinical Microbiology and Infectious Diseases
2 Concise Communication Table BAL bactericidal activity tested by time±kill curves against strains of Gram-positive cocci at concentrations of, and mg/l Organism/strain number Susceptibility (MIC (mg/l),category) phenotype a Activity at concentration (mg/l) Streptococcus pneumoniae -B Penicillin (., I) Bactericidal b Bactericidal Bactericidal -B Penicillin (, R) Bactericidal Bactericidal Bactericidal -B Penicillin (, R) Bactericidal Bactericidal Bactericidal Viridans group streptococci -A Penicillin (., S) Bactericidal Bactericidal Bactericidal -A Penicillin (., I) Bactericidal Bactericidal Bactericidal -C Penicillin (, R) Bactericidal Bactericidal Bactericidal Staphylococcus aureus ATCC Oxacillin (., S) Bactericidal Bactericidal Bactericidal -A Oxacillin (., S) Bactericidal Bactericidal Bactericidal -A Oxacillin (>, R) Bactericidal Bactericidal Bactericidal Mu c Oxacillin (>, R) Bactericidal Bactericidal Bactericidal CoNS d -A Oxacillin (., S) Bactericidal Bactericidal Static e -A Oxacillin (., S) Bactericidal Bactericidal Bactericidal -A Oxacillin (>, R) Bactericidal Bactericidal Bactericidal -A Oxacillin (>, R) Bactericidal Bactericidal Bactericidal E. faecalis ATCC Ampicillin (, S) Bactericidal Bactericidal Bactericidal E. faecium -A Ampicillin (, S) f Bactericidal Bactericidal Bactericidal -A Ampicillin (, S) f Static Static Static -A Ampicillin (>, R) g g g -A Ampicillin (>, R) g g g a S, susceptible; I, intermediate; R, resistant. b Bactericidal activity defined by log decrease in the initial inoculum (approximately to CFU/mL). c Vancomycin-intermediate Staphylococcus aureus MRSA from Hiramatsu et al. []. d CoNS, coagulase-negative staphylococci. e Bactericidal activity was noted at h, but regrowth occurred to CFU/mL at h. f Strain was quinupristin±dalfopristin resistant. g No inhibition was observed, as the BAL MIC parallels the MIC of ampicillin. described in the ASM Manual of Clinical Microbiology []. Each experiment was accompanied by a growth control with no antimicrobial agent. A - ml sample was used to determine colony counts at,, and h (streptococci) or,,, and h (enterococci and staphylococci) of incubation. Cidal activity was measured at three concentrations (, and mg/l) against Streptococcus pneumoniae (three strains), viridans group streptococci (three strains), Staphylococcus aureus (four strains), coagulase-negative staphylococci (CoNS; four strains), Enterococcus faecalis (one strain), and E. faecium (four strains), giving strains in total. These concentrations were selected to simulate expected serum peaks for BAL in human subjects that approach mg/l. Synergistic interactions between BAL and gentamicin were determined against staphylococci ( strains) and enterococci (two E. faecalis and eight E. faecium strains) with BAL MIC values of mg/l and without high-level resistance to gentamicin; see Table for susceptibilities to other agents. All staphylococci were resistant to methicillin (oxacillin), and enterococci showed varying degrees of resistance to vancomycin or ampicillin (Table ). No streptococci were studied because of the favorable cidal activity of BAL when tested alone against these species. BAL was tested at mg/l ( MIC) and gentamicin at MIC/. Synergy was de ned as log (at ± h) and log (at h) CFU/mL greater killing for the combination (BAL gentamicin) when compared to BAL alone []. RESULTS AND DISCUSSION Streptococcus pneumoniae and viridans group streptococci are generally very susceptible to BAL
3 Clinical Microbiology and Infection, Volume Number, November Table Results of BAL drug interaction (synergy) experiments using combinations with gentamicin (MIC/) and the time±kill curve method against various resistant and susceptible phenotype strains of staphylococci and enterococci a Activity for b Organism/strain number Susceptibility phenotype (MIC (mg/l),category) Strain origin BAL alone BAL gentamicin Interaction category c Staphylococcus aureus -C Oxacillin (>, R) USA Bactericidal Bactericidal Indifferent -C Oxacillin (>, R) USA Bactericidal Bactericidal Indifferent -A Oxacillin (>, R) USA Bactericidal Bactericidal Indifferent CoNS d -A Oxacillin (>, R) USA Bactericidal Bactericidal Indifferent -A Oxacillin (, R) USA Bactericidal Bactericidal Indifferent -A Oxacillin (, R) Canada Bactericidal Bactericidal Synergy -A Oxacillin (, R) Canada Bactericidal Bactericidal Indifferent -A Oxacillin (>, R) Brazil Bactericidal Bactericidal Indifferent -A Oxacillin (>, R) Turkey Bactericidal Bactericidal Indifferent -A Oxacillin (>, R) France Bactericidal Bactericidal Synergy E. faecalis -A Vancomycin (, S) e USA Bactericidal Bactericidal Indifferent -A Vancomycin (, S) e Canada Bactericidal Bactericidal Indifferent E. faecium -I Vancomycin (., S) e USA Bactericidal Bactericidal Synergy -A Vancomycin (, S) e USA Static Bactericidal Synergy -A Vancomycin (, I) e USA Static Bactericidal Synergy -A Vancomycin (, S) e Canada Bactericidal Bactericidal Synergy -A Vancomycin (., S) e Canada Bactericidal Bactericidal Indifferent -A Vancomycin (, S) e France Static Bactericidal Synergy -A Vancomycin (., S) e Spain Static Bactericidal Indifferent -A Vancomycin (., S) e Germany Bactericidal Bactericidal Indifferent a All strains were tested at a BAL concentration of mg/l. Gentamicin was tested at MIC/ alone and with BAL. b Bactericidal activity was defined as noted in Table, footnote b. c Interactive categories were defined as follows: synergy if the combination exhibits log superior killing compared to BAL alone; antagonism if the combination exhibits log inferior killing compared to BAL alone; `indifferent' was used for all variations between the above-defined extremes. d CoNS, coagulase-negative staphylococci. e These strains were also susceptible to ampicillin (MIC mg/l). and exhibit a slightly negative in uence of penicillin resistance on BAL MIC results []. However, as shown in Table, BAL has cidal action against all the streptococci, regardless of their penicillin MIC. Figure exhibits modest concentration-dependent killing by BAL, found for a minority of strains at h. There was no difference in the rate of killing at and h of incubation based on drug concentration. BAL shows cidal action against the S. aureus isolates. Oxacillin-susceptible and -resistant isolates, including the vancomycin-intermediate strain Mu, were killed by BAL [] with a mg/l concentration suf cient to produce a log CFU/mL reduction in the viable cell count. There were reduced killing effects at and mg/ L of BAL for some isolates, as indicated in Figure. Such `Eagle effects' [] were observed in CFU (Log ) mg/l mg/l mg/l Figure Time±kill curve for Streptococcus pneumoniae - C (BAL MIC,. mg/l) using BAL concentrations of, and mg/l.
4 Concise Communication CFU (Log ) mg/l mg/l mg/l Figure Time±kill curve for Staphylococcus aureus -A (BAL MIC,. mg/l) using BAL concentrations of, and mg/l. All concentrations achieved bactericidal action, but an `Eagle effect' was detected. the staphylococci ATCC, CoNS -A and SA -A. One staphylococcal isolate (- A) showing cidal action at h with mg BAL/L exhibited regrowth at h; this was categorized as a static effect (Table ). Bactericidal activity of BAL was observed against ampicillin-susceptible enterococci, while it remained static versus the isolate with an elevated, yet susceptible, ampicillin MIC (-A; Table ). Ampicillin resistance in E. faecium correlates with BAL resistance, so no inhibition was noted in the ampicillin-resistant isolates. Table shows the assessment of synergistic action between BAL and gentamicin. The combination was bactericidal against all the staphylococci and enterococci tested. For some of the enterococci, it expanded the static action of BAL alone to a bactericidal level. Thus, based on the log CFU/mL superior killing criteria (versus BAL alone) for synergy, the activity of the combination was categorized as either indifferent or synergistic (Table ). Figure presents a classic example of synergy as observed with the addition of subinhibitory concentrations of gentamicin (MIC/) to BAL among the enterococci. BAL showed generally bactericidal action against the streptococci, most staphylococci and ampicillin-susceptible enterococci tested. In our previously reported experience, we found that BAL has only modest activity against enterococci, especially E. faecium [], since it shares coresistance to ampicillin. Some Staphylococcus CFU (Log ) strains exhibited an `Eagle effect', common to numerous b-lactams. Gentamicin interaction with BAL was categorized as either indifference or synergy. None of the isolates tested showed an antagonistic interaction. BAL alone and in combination showed signi cant bactericidal activity against resistant Gram-positive pathogens, and these results warrant further clinical evaluation of this broad-spectrum compound. A safe b-lactam active against resistant Gram-positive cocci such as MRSA would be a welcome addition to contemporary chemotherapy in the hospital setting. ACKNOWLEDGMENTS The study was made possible by an educational/ research grant from Basilea Pharmaceuticals. REFERENCES BAL mg/l MIC/ Combination Figure BAL synergy experiment with gentamicin (MIC/) using E. faecium -A (ampicillin and vancomycin susceptible).. Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P. BAL, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicrob Agents Chemother ; : ±.. Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page M, Then R. In vitro and in vivo properties of Ro-, a novel broad spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob Agents Chemother ; : ±.. Jones RN, Deshpande LM, Mutnick AL, Biedenbach DJ. In vitro evaluation of BAL, a novel cephalosporin active against oxacillin-resistant staphylococci. J Antimicrob Chemother ; : ±.
5 Clinical Microbiology and Infection, Volume Number, November. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, th edn. Approved standard M-A. Wayne, PA: NCCLS,.. National Committee for Clinical Laboratory Standards. MIC testing. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. M-S. Wayne, PA: NCCLS,.. Krapp C, Moody JA. Timed kill assay for determining synergy. In: Isenberg HD, ed. ASM manual of clinical microbiology. Washington, DC: ASM Press, : S.... Eagle H, Musselman AD. The rate of bactericidal action of penicillin in vitro as a function of its concentration and its paradoxically reduced activity at high concentration against certain organisms. J Exp Med ; : ±.. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother ; : ±.
against Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationAn Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus
Article ID: WMC00590 ISSN 2046-1690 An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus Author(s):Dr. K P Ranjan, Dr. D R Arora, Dr. Neelima Ranjan Corresponding
More informationDalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01051.x Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres A. C. Gales 1, H. S. Sader 1,2
More informationMICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,
More informationIn vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative
Journal of Antimicrobial Chemotherapy (2008) 62, 116 121 doi:10.1093/jac/dkn124 Advance Access publication 19 April 2008 In vitro activity of telavancin against recent Gram-positive clinical isolates:
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationActivity of Linezolid Tested Against Uncommonly Isolated Gram-positive ACCEPTED
AAC Accepts, published online ahead of print on 8 January 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01496-06 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationOver the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.
Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing
More informationIn Vitro Activities of the Novel Cephalosporin LB against Multidrug-Resistant Staphylococci and Streptococci
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2004, p. 53 62 Vol. 48, No. 1 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.1.53 62.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationSUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.
SUPPLEMENT ARTICLE Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe,
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01550.x Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002 2004)
More informationDoripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
REVIEW Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities Fiona Walsh Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland
More informationAntimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil
BJID 2001; 5 (August) 171 Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil Helio S. Sader, Ana C. Gales and Ronald N. Jones Special Clinical Microbiology Laboratory, Division
More informationDynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationKey words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin
Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationIn vitro Activity Evaluation of Telavancin against a Contemporary Worldwide Collection of Staphylococcus. aureus. Rodrigo E. Mendes, Ph.D.
AAC Accepts, published online ahead of print on 12 April 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00301-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationOriginal Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.
Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services
More informationAntibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus
B-O-021 Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus Nongluk Autarkool *a, Yothin Teethaisong a, Sajeera Kupittayanant b, Griangsak Eumkeb a
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationOriginal Article. Suwanna Trakulsomboon, Ph.D., Visanu Thamlikitkul, M.D.
Original Article Vol. 25 No. 2 In vitro activity of daptomycin against MRSA:Trakulsomboon S & Thamlikitkul V. 57 In Vitro Activity of Daptomycin against Methicillin- Resistant Staphylococcus aureus (MRSA)
More informationSURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS
SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS Adrienn Hanczvikkel 1, András Vígh 2, Ákos Tóth 3,4 1 Óbuda University, Budapest,
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationManagement of Native Valve
Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationRESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN
RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI
HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus
More informationComparative Antimicrobial Activities of Linezolid and Vancomycin against Gram-Positive Clinical Isolates from Hospitals in Kuwait
Original Paper Med Principles Pract 2001;10:177 181 Received: June 24, 2001 Revised: September 29, 2001 Comparative Antimicrobial Activities of Linezolid and Vancomycin against Gram-Positive Clinical Isolates
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationOccurrence of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Srinagarind Hospital
Original Article Occurrence of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Srinagarind Hospital Aroonlug Lulitanond, M.Sc. 1,3 Aroonwadee Chanawong, Ph.D. 1,3
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationSusceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System
Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationJasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4
JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2372 2377 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2372 2377.2003 The World Health Organization s External Quality Assurance System Proficiency
More informationWhat s new and not so new on the antimicrobial horizon? G. L. French
REVIEW 10.1111/j.1469-0691.2008.02124.x What s new and not so new on the antimicrobial horizon? G. L. French Department of Infection, King s College and Guy s and St Thomas Hospital, London, UK ABSTRACT
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationAminoglycoside-resistant enterococci
Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationJ. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh
Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 75 80 JAC In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationDetection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital
ISSN: 2319-7706 Volume 3 Number 9 (2014) pp. 689-694 http://www.ijcmas.com Original Research Article Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a
More informationBJID 2001; 5 (February) 21
BJID 2001; 5 (February) 21 Antimicrobial Susceptibility of Quinupristin/Dalfopristin Tested Against Gram-Positive Cocci From Latin America: Results from the Global SMART (GSMART) Surveillance Study Helio
More informationMichael T. Sweeney* and Gary E. Zurenko. Infectious Diseases Biology, Pharmacia Corporation, Kalamazoo, Michigan 49007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2003, p. 1902 1906 Vol. 47, No. 6 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.6.1902 1906.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationNosocomial Bloodstream Infections: Organisms, Risk Factors, and Implications
S139 Nosocomial Bloodstream Infections: Organisms, Risk Factors, and Implications Adolf W. Karchmer Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationExtremely Drug-resistant organisms: Synergy Testing
Extremely Drug-resistant organisms: Synergy Testing Background Acinetobacter baumannii& Pseudomonas aeruginosa Emerging Gram-negative bacilli Part of the ESKAPE group of organisms 1 Enterococcus faecium
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationComparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme,
European Journal of Clinical Microbiology & Infectious Diseases (2018) 37:1653 1659 https://doi.org/10.1007/s10096-018-3295-6 ORIGINAL ARTICLE Comparative activity of ceftobiprole against coagulase-negative
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Healthcare Associated
More informationTest Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants
Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationZyvox w Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years ( )
J Antimicrob Chemother 2014; 69: 1582 1588 doi:10.1093/jac/dkt541 Advance Access publication 26 January 2014 Zyvox w Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationMethicillin resistant Staphylococcus aureus : a multicentre study
Methicillin resistant Staphylococcus aureus : a multicentre study S. Hafiz ( Mid-East Medical Center,Karachi. ) A. N. Hafiz ( Mid-East Medical Center, Karachi. ) L. Ali ( City Medical Laboratory, Peshawer,
More informationLeveraging the Lab and Microbiology Department to Optimize Stewardship
Leveraging the Lab and Microbiology Department to Optimize Stewardship Presented by: Andrew Martinez MLS(ASCP), MT(AMT), MBA Alaska Native Medical Center Microbiology Supervisor Maniilaq Health Center
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationConsiderations for antibiotic therapy. Christoph K. Naber Interventional Cardiology Heartcenter - Elisabeth Hospital Essen
Considerations for antibiotic therapy Christoph K. Naber Interventional Cardiology Heartcenter - Elisabeth Hospital Essen Infective Endocarditis There will never be a cure for this malignant disease! Sir
More informationOpen Access. The Open Microbiology Journal, 2008, 2,
The Open Microbiology Journal, 2008, 2, 79-84 79 Open Access In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin- Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis
More informationSynergy of Daptomycin with Oxacillin and Other -Lactams against Methicillin-Resistant Staphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 2871 2875 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.2871 2875.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationWhat s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationA Norazah, M D*, V K E Lim, FRCPath**, MY Rohani, MPath*, A G M Kamel, MD**,
I ORIGINAL ARTICLE In-Vitro Activity of Quinupristin/ Dalfopristin, Levofloxacin and Moxifloxacin Against Fusidic Acid and Rifampicin-Resistant Strains of Methicillin Resistant Staphylococcus Aureus (MRSA)
More informationSurveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler
Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations
More informationPathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,
Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California, 2007-2012 Geraldine R. Slean, MD, MS 1 ; Neal H. Shorstein, MD 2 ; Liyan Liu, MD, MS
More informationExploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
Supplementary materials Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent Shankar Thangamani 1, Haroon Mohammad 1, Mostafa Abushahba 1, Maha Hamed 1, Tiago Sobreira
More information